Savara Inc (SVRA)

Dec 08, 2025

Savara stock hits 52-week high at 6.61 USD By Investing.com - Investing.com Canada

Dec 08, 2025

Dec 08, 2025

Certain Options of Savara Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com

Dec 08, 2025

Dec 08, 2025

Certain Warrants of Savara Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com

Dec 08, 2025

Dec 08, 2025

172,836,922 Common Stock of Savara Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com

Dec 08, 2025

Dec 07, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Dec 07, 2025

Dec 06, 2025

Savara (NASDAQ:SVRA) Sees Strong Trading VolumeStill a Buy? - MarketBeat

Dec 06, 2025

Dec 06, 2025

Affinity Asset Advisors LLC Purchases New Stake in Savara Inc. $SVRA - MarketBeat

Dec 06, 2025

Dec 06, 2025

Savara issues patent for Molbreevi from European Patent Office - MSN

Dec 06, 2025

Dec 05, 2025

Savara rumor highlighted in Betaville blog - MSN

Dec 05, 2025

Dec 05, 2025

How strong dollar benefits Savara Inc. (YB4P) stock2025 Market WrapUp & Low Drawdown Investment Ideas - Newser

Dec 05, 2025

Dec 04, 2025

Dir Elam Acquires 4,387 Of Savara Inc [SVRA] - TradingView

Dec 04, 2025

Dec 04, 2025

Savara Inc. (SVRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Dec 04, 2025

Dec 04, 2025

Is Savara Inc. (YB4P) stock supported by free cash flowDip Buying & Daily Price Action Insights - Newser

Dec 04, 2025

Dec 04, 2025

Savara (NASDAQ:SVRA) Shares Up 6.8%What's Next? - MarketBeat

Dec 04, 2025

Dec 04, 2025

Savara (SVRA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025

Dec 04, 2025

Savara (NASDAQ:SVRA) Reaches New 1-Year HighShould You Buy? - MarketBeat

Dec 04, 2025

Dec 04, 2025

Will Savara Inc. (YB4P) stock boost dividends furtherWeekly Trade Recap & Breakout Confirmation Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Is Savara Inc. stock trading near support levelsRecession Risk & AI Optimized Trade Strategies - Newser

Dec 04, 2025

Dec 04, 2025

Is Savara Inc. (YB4P) stock a top pick for value investorsEarnings Recap Summary & High Return Stock Watch Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Savara (NASDAQ:SVRA) Nasdaq Today Specialized Biotech Direction - Kalkine Media

Dec 04, 2025

Dec 04, 2025

Savara Inc. ticks higher amid takeover speculation - MSN

Dec 04, 2025

Dec 03, 2025

Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System - BioSpace

Dec 03, 2025

Dec 03, 2025

Savara receives European patent for PAP treatment device By Investing.com - Investing.com Canada

Dec 03, 2025

Dec 03, 2025

Why analysts upgrade Savara Inc. stockTrade Volume Summary & Weekly High Return Forecasts - Newser

Dec 03, 2025

Dec 03, 2025

Savara (SVRA) Climbs 27.8% Ahead of 2 Health Conferences - MSN

Dec 03, 2025

Dec 02, 2025

Savara to Spotlight Lead Therapy in Fireside Chats at Major Healthcare Conferences - MSN

Dec 02, 2025

Dec 02, 2025

Savara Inc. (SVRA) Rises Amid Takeover Speculation - GuruFocus

Dec 02, 2025

Dec 02, 2025

Savara (SVRA) Market Activity Stirred by Acquisition Rumor - GuruFocus

Dec 02, 2025

Dec 02, 2025

Savara Inc. ticks higher amid takeover speculation (SVRA:NASDAQ) - Seeking Alpha

Dec 02, 2025

Dec 02, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Savara Inc. (SVRA) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Dec 02, 2025

Dec 02, 2025

Savara (NASDAQ:SVRA) Shares Gap DownHere's Why - MarketBeat

Dec 02, 2025

Dec 02, 2025

Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Deliver - PharmiWeb.com

Dec 02, 2025

Dec 02, 2025

Savara, PARI Granted European Patent Covering Drug-Device Combination - marketscreener.com

Dec 02, 2025

Dec 02, 2025

Savara (SVRA) Secures European Patent for Drug-Device Combo - GuruFocus

Dec 02, 2025

Dec 02, 2025

Savara receives European patent for PAP treatment device - Investing.com

Dec 02, 2025

Dec 02, 2025

Is Savara Inc. (YB4P) stock a top hedge fund pickBull Run & Verified Stock Trade Ideas - Newser

Dec 02, 2025

Dec 01, 2025

F m Investments LLC Acquires 91,830 Shares of Savara Inc. $SVRA - MarketBeat

Dec 01, 2025

Dec 01, 2025

10 Small Caps With Big Double-Digit Gains - Insider Monkey

Dec 01, 2025

Nov 30, 2025

Savara to Resubmit BLA for Rare Lung Disease Treatment as Losses Widen in Q2 - MSN

Nov 30, 2025

Nov 30, 2025

Savara Stock Surges Amid Positive Financial Developments and Raised Price Target - timothysykes.com

Nov 30, 2025

Nov 29, 2025

Savara Inc. Sees Price Target Raised Amid Promising Drug Developments - StocksToTrade

Nov 29, 2025

Nov 29, 2025

Savara Inc’s Stock Boosted by Strategic Financial Moves and Developments - StocksToTrade

Nov 29, 2025

Nov 29, 2025

Savara’s Strategic Moves Strengthen Market Position with Price Target Increase - timothysykes.com

Nov 29, 2025

Nov 28, 2025

Savara Stock: Will It Continue to Rise? - StocksToTrade

Nov 28, 2025

Nov 28, 2025

Savara Inc. (SVRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 28, 2025